These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14529452)

  • 1. The quinolone family: from antibacterial to anticancer agents.
    Sissi C; Palumbo M
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):439-50. PubMed ID: 14529452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonclassical biological activities of quinolone derivatives.
    Ahmed A; Daneshtalab M
    J Pharm Pharm Sci; 2012; 15(1):52-72. PubMed ID: 22365088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized N(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents.
    Rajabalian S; Foroumadi A; Shafiee A; Emami S
    J Pharm Pharm Sci; 2007; 10(2):153-8. PubMed ID: 17706174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.
    Anderson VE; Osheroff N
    Curr Pharm Des; 2001 Mar; 7(5):337-53. PubMed ID: 11254893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
    Pommier Y; Leo E; Zhang H; Marchand C
    Chem Biol; 2010 May; 17(5):421-33. PubMed ID: 20534341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumour activities of quinolone antineoplastic agents.
    Chu DT; Hallas R; Clement JJ; Alder J; McDonald E; Plattner JJ
    Drugs Exp Clin Res; 1992; 18(7):275-82. PubMed ID: 1338309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.
    Bisacchi GS; Hale MR
    Curr Med Chem; 2016; 23(6):520-77. PubMed ID: 26695512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the discovery and development of quinolones and analogs as antitumor agents.
    Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
    Curr Med Chem; 1999 Mar; 6(3):179-94. PubMed ID: 10219099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards anticancer fluoroquinolones: A review article.
    Abdel-Aal MAA; Abdel-Aziz SA; Shaykoon MSA; Abuo-Rahma GEA
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800376. PubMed ID: 31215674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of modified quinolones as antitumoral acridones.
    Tabarrini O; Cecchetti V; Fravolini A; Nocentini G; Barzi A; Sabatini S; Miao H; Sissi C
    J Med Chem; 1999 Jun; 42(12):2136-44. PubMed ID: 10377219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
    Mitscher LA
    Chem Rev; 2005 Feb; 105(2):559-92. PubMed ID: 15700957
    [No Abstract]   [Full Text] [Related]  

  • 12. Quinoline and quinolone dimers and their biological activities: An overview.
    Chu XM; Wang C; Liu W; Liang LL; Gong KK; Zhao CY; Sun KL
    Eur J Med Chem; 2019 Jan; 161():101-117. PubMed ID: 30343191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study.
    Foroumadi A; Emami S; Rajabalian S; Badinloo M; Mohammadhosseini N; Shafiee A
    Biomed Pharmacother; 2009 Mar; 63(3):216-20. PubMed ID: 18328669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity.
    Naeem A; Badshah SL; Muska M; Ahmad N; Khan K
    Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase as target for antibacterial and anticancer drug discovery.
    Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor.
    Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A
    Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on the development of novel potentially active quinolones against tuberculosis and cancer.
    Facchinetti V; Gomes CR; de Souza MV; Vasconcelos TR
    Mini Rev Med Chem; 2012 Aug; 12(9):866-74. PubMed ID: 22512569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumour activities of tetracyclic quinolone antineoplastic agents.
    Chu DT; Hallas R; Tanaka SK; Alder J; Balli D; Plattner JJ
    Drugs Exp Clin Res; 1994; 20(5):177-83. PubMed ID: 7875053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.